Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2001 Dec 17;11(24):3111-3.

Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weight.

Author information

1
Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. kliu@kalypsys.com

Abstract

A series of PPARgamma agonists were synthesized from L-tyrosine that incorporated low molecular weight N-substituents. The most potent analogue, pyrrole (4e), demonstrated a K(i) of 6.9nM and an EC(50) of 4.7nM in PPARgamma binding and functional assays, respectively. Pyrrole (4e), which is readily synthesized from L-tyrosine methyl ester in four steps, also demonstrated in vivo activity in a rodent model of Type 2 diabetes.

PMID:
11720854
DOI:
10.1016/s0960-894x(01)00649-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center